MW
Meridian Wealth Partners, LLC
13F filer · CIK 0001781942Reported Aug 12, 2026
Net seller this quarter
13F portfolio value$826MU.S. long equity reported on 13F
Positions7813 new · 6 closed
Net flow last quarter-$2.06MBuys minus sells
Top 10 positions weight12.1%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 12, 202678 positions | |||||
| $34M | 4.12% | Not reported | -8.6% | Q4 2020 | |
| $31.1M | 3.77% | Not reported | -0.9% | Q3 2021 | |
| $10.5M | 1.28% | 0.00% | -2.8% | Q4 2019 | |
| $9.48M | 1.15% | 0.04% | -1.2% | Q4 2019 | |
| $4.36M | 0.53% | 0.00% | +3.3% | Q4 2019 | |
| $2.78M | 0.34% | 0.00% | +3.5% | Q4 2019 | |
| $2.12M | 0.26% | 0.00% | +7.2% | Q4 2019 | |
| $1.85M | 0.22% | 0.00% | +3.2% | Q4 2019 | |
| $1.84M | 0.22% | 0.00% | -3.8% | Q4 2019 | |
| $1.8M | 0.22% | 0.00% | +0.3% | Q4 2019 | |
| $1.79M | 0.22% | 0.01% | Not reported | Q1 2026 | |
| $1.47M | 0.18% | 0.00% | +2.7% | Q4 2020 | |
| $1.34M | 0.16% | 0.56% | 0.0% | Q4 2019 | |
| $1.33M | 0.16% | Not reported | +1.2% | Q4 2019 | |
| $1.32M | 0.16% | 0.00% | -24.7% | Q1 2021 | |
| $1.05M | 0.13% | Not reported | +4.0% | Q4 2019 | |
| $965K | 0.12% | 0.00% | +19.3% | Q1 2021 | |
| $961K | 0.12% | 0.00% | +13.2% | Q4 2019 | |
| $928K | 0.11% | 0.00% | +0.3% | Q4 2019 | |
| $900K | 0.11% | 0.00% | Not reported | Q4 2019 | |
| $840K | 0.10% | 0.00% | -0.2% | Q4 2019 | |
| $778K | 0.09% | 0.00% | +1.3% | Q4 2019 | |
| $749K | 0.09% | Not reported | Not reported | Q1 2025 | |
| $731K | 0.09% | 0.02% | Not reported | Q4 2019 | |
| $728K | 0.09% | 0.00% | +5.4% | Q4 2019 | |
| $706K | 0.09% | 0.00% | +0.5% | Q2 2020 | |
| $666K | 0.08% | 0.01% | +0.1% | Q4 2019 | |
| $582K | 0.07% | Not reported | -14.1% | Q4 2019 | |
| $538K | 0.07% | 0.00% | +1.6% | Q4 2019 | |
| $535K | 0.06% | 0.00% | +4.0% | Q4 2019 | |
| $517K | 0.06% | 0.00% | -0.8% | Q4 2020 | |
| $515K | 0.06% | 0.00% | -13.0% | Q4 2019 | |
| $496K | 0.06% | 0.00% | -12.1% | Q4 2019 | |
| $492K | 0.06% | 0.00% | +6.0% | Q4 2019 | |
| $468K | 0.06% | Not reported | Not reported | Q4 2019 | |
| $461K | 0.06% | 0.00% | -4.2% | Q4 2019 | |
| $425K | 0.05% | 0.00% | Not reported | Q4 2019 | |
| $423K | 0.05% | 0.00% | +2.2% | Q4 2025 | |
| $422K | 0.05% | 0.00% | -0.7% | Q4 2019 | |
| $421K | 0.05% | 0.00% | -0.5% | Q2 2020 | |
| $418K | 0.05% | 0.00% | +1.8% | Q4 2020 | |
| $405K | 0.05% | 0.00% | -1.7% | Q4 2019 | |
| $404K | 0.05% | 0.00% | +3.0% | Q4 2019 | |
| $386K | 0.05% | 0.00% | +19.7% | Q4 2019 | |
| $353K | 0.04% | 0.00% | -1.7% | Q4 2019 | |
| $352K | 0.04% | 0.00% | +0.8% | Q4 2019 | |
| $347K | 0.04% | 0.00% | -10.4% | Q4 2019 | |
| $322K | 0.04% | 0.00% | Not reported | Q1 2021 | |
| $320K | 0.04% | 0.00% | Not reported | Q4 2019 | |
| $317K | 0.04% | 0.00% | +0.8% | Q4 2019 | |
| Q1 2026Reported May 14, 202671 positions | |||||
| $29M | 3.97% | Not reported | -3.7% | Q3 2021 | |
| $26.5M | 3.63% | Not reported | +1.4% | Q4 2020 | |
| $9.51M | 1.31% | 0.00% | +1.5% | Q4 2019 | |
| $8.45M | 1.16% | 0.04% | -2.0% | Q4 2019 | |
| $3.68M | 0.51% | 0.00% | +10.8% | Q4 2019 | |
| $2.66M | 0.37% | 0.00% | +4.7% | Q4 2019 | |
| $1.79M | 0.25% | 0.00% | -0.6% | Q4 2019 | |
| $1.73M | 0.24% | 0.01% | New | Q1 2026 | |
| $1.73M | 0.24% | 0.00% | +10.9% | Q4 2019 | |
| $1.44M | 0.20% | 0.00% | -5.8% | Q4 2019 | |
| $1.27M | 0.17% | 0.56% | Not reported | Q4 2019 | |
| $1.18M | 0.16% | 0.00% | +4.1% | Q4 2020 | |
| $1.17M | 0.16% | 0.00% | +0.7% | Q4 2019 | |
| $1.06M | 0.15% | Not reported | +3.1% | Q4 2019 | |
| $1.05M | 0.14% | 0.00% | Not reported | Q4 2019 | |
| $1.02M | 0.14% | Not reported | -1.8% | Q4 2019 | |
| $953K | 0.13% | 0.00% | +1.9% | Q4 2019 | |
| $832K | 0.11% | 0.00% | -0.5% | Q4 2019 | |
| $809K | 0.11% | 0.00% | +32.7% | Q4 2019 | |
| $750K | 0.10% | 0.00% | +1.6% | Q4 2019 | |
| CPCNTACentessa Pharmaceuticals PLC | $719K | 0.10% | 0.01% | Not reported | Q2 2025 |
| $718K | 0.10% | Not reported | Not reported | Q1 2025 | |
| $639K | 0.09% | 0.02% | Not reported | Q4 2019 | |
| $619K | 0.08% | 0.00% | -18.0% | Q4 2019 | |
| $614K | 0.08% | 0.00% | +4.9% | Q1 2021 | |
| $608K | 0.08% | 0.00% | +8.4% | Q2 2020 | |
| $581K | 0.08% | 0.00% | +4.4% | Q4 2019 | |
| $560K | 0.08% | 0.02% | Not reported | Q4 2019 | |
| $553K | 0.08% | 0.00% | -0.2% | Q4 2019 | |
| $531K | 0.07% | Not reported | +84.7% | Q4 2019 | |
| $529K | 0.07% | 0.00% | +2.9% | Q4 2019 | |
| $504K | 0.07% | 0.00% | Not reported | Q4 2019 | |
| $478K | 0.07% | 0.00% | Not reported | Q4 2019 | |
| $441K | 0.06% | 0.00% | +6.7% | Q4 2019 | |
| $430K | 0.06% | 0.00% | +14.5% | Q2 2020 | |
| $409K | 0.06% | 0.00% | -0.6% | Q4 2019 | |
| $407K | 0.06% | Not reported | +3.3% | Q4 2019 | |
| $372K | 0.05% | 0.00% | +1.5% | Q4 2019 | |
| $372K | 0.05% | 0.00% | +9.1% | Q4 2019 | |
| $359K | 0.05% | 0.00% | +25.6% | Q4 2019 | |
| $356K | 0.05% | 0.00% | +7.4% | Q4 2019 | |
| $332K | 0.05% | 0.00% | +7.7% | Q1 2020 | |
| $324K | 0.04% | 0.00% | +3.3% | Q4 2019 | |
| $307K | 0.04% | 0.00% | -5.2% | Q4 2019 | |
| $306K | 0.04% | 0.00% | +1.8% | Q4 2019 | |
| $293K | 0.04% | 0.00% | -4.0% | Q4 2019 | |
| $276K | 0.04% | 0.00% | Not reported | Q4 2019 | |
| $273K | 0.04% | 0.00% | +3.2% | Q4 2020 | |
| $267K | 0.04% | 0.00% | +0.9% | Q4 2019 | |
| $265K | 0.04% | 0.00% | +0.8% | Q4 2019 | |
| Q4 2025Reported Feb 13, 202667 positions | |||||
| $29M | 3.99% | Not reported | -6.4% | Q3 2021 | |
| $25.1M | 3.46% | Not reported | +0.9% | Q4 2020 | |
| $10M | 1.38% | 0.00% | -3.9% | Q4 2019 | |
| $8.27M | 1.14% | 0.04% | -2.1% | Q4 2019 | |
| $3.55M | 0.49% | 0.00% | -3.2% | Q4 2019 | |
| $3.32M | 0.46% | 0.00% | -3.2% | Q4 2019 | |
| $1.88M | 0.26% | 0.00% | -1.0% | Q4 2019 | |
| $1.72M | 0.24% | 0.00% | -4.4% | Q4 2019 | |
| $1.67M | 0.23% | 0.00% | -26.1% | Q4 2019 | |
| $1.26M | 0.17% | 0.00% | -0.4% | Q4 2020 | |
| $1.2M | 0.17% | Not reported | -27.7% | Q4 2019 | |
| $1.18M | 0.16% | 0.57% | -7.5% | Q4 2019 | |
| $1.13M | 0.16% | Not reported | -4.5% | Q4 2019 | |
| $1.04M | 0.14% | 0.00% | -4.4% | Q4 2019 | |
| $968K | 0.13% | 0.00% | -4.3% | Q4 2019 | |
| $926K | 0.13% | 0.00% | -0.1% | Q4 2019 | |
| $916K | 0.13% | 0.00% | -4.2% | Q4 2019 | |
| $894K | 0.12% | 0.00% | -2.3% | Q4 2019 | |
| $755K | 0.10% | Not reported | Not reported | Q1 2025 | |
| $663K | 0.09% | 0.00% | -10.1% | Q4 2019 | |
| $626K | 0.09% | 0.02% | -0.3% | Q4 2019 | |
| $616K | 0.08% | 0.00% | +0.5% | Q1 2021 | |
| $601K | 0.08% | 0.00% | -2.8% | Q4 2019 | |
| $589K | 0.08% | 0.00% | -2.8% | Q2 2020 | |
| $545K | 0.08% | 0.00% | -0.2% | Q4 2019 | |
| $532K | 0.07% | 0.02% | Not reported | Q4 2019 | |
| $517K | 0.07% | 0.00% | +0.4% | Q4 2019 | |
| $499K | 0.07% | 0.00% | -3.7% | Q4 2019 | |
| $478K | 0.07% | 0.00% | -2.9% | Q4 2019 | |
| CPCNTACentessa Pharmaceuticals PLC | $453K | 0.06% | 0.01% | Not reported | Q2 2025 |
| $422K | 0.06% | 0.00% | -2.3% | Q4 2019 | |
| $416K | 0.06% | 0.00% | -4.5% | Q4 2019 | |
| $413K | 0.06% | Not reported | Not reported | Q4 2019 | |
| $370K | 0.05% | 0.00% | +0.9% | Q1 2021 | |
| $365K | 0.05% | 0.00% | +5.3% | Q4 2019 | |
| $364K | 0.05% | 0.00% | +44.5% | Q4 2019 | |
| $362K | 0.05% | 0.00% | +22.8% | Q4 2019 | |
| $357K | 0.05% | 0.00% | -3.0% | Q2 2020 | |
| $344K | 0.05% | 0.00% | -4.8% | Q4 2019 | |
| $306K | 0.04% | Not reported | Not reported | Q4 2019 | |
| $303K | 0.04% | 0.00% | -16.0% | Q4 2019 | |
| $301K | 0.04% | 0.00% | +1.1% | Q1 2020 | |
| $295K | 0.04% | 0.00% | -6.8% | Q4 2019 | |
| $284K | 0.04% | 0.00% | -1.0% | Q1 2021 | |
| $283K | 0.04% | 0.00% | New | Q4 2025 | |
| $277K | 0.04% | 0.00% | -8.4% | Q4 2019 | |
| $266K | 0.04% | 0.00% | -0.4% | Q4 2019 | |
| $258K | 0.04% | 0.00% | -4.4% | Q4 2019 | |
| $250K | 0.03% | 0.00% | +1.8% | Q4 2019 | |
| $249K | 0.03% | 0.00% | -1.1% | Q3 2025 | |
| Q3 2025Reported Nov 13, 202564 positions | |||||
| $29.7M | 4.08% | Not reported | -0.5% | Q3 2021 | |
| $22.8M | 3.13% | Not reported | +4.0% | Q4 2020 | |
| $9.79M | 1.35% | 0.00% | -4.3% | Q4 2019 | |
| $8.66M | 1.19% | 0.04% | -35.8% | Q4 2019 | |
| $3.67M | 0.51% | 0.00% | -9.2% | Q4 2019 | |
| $3.67M | 0.50% | 0.00% | -29.1% | Q4 2019 | |
| $2.24M | 0.31% | 0.00% | -10.2% | Q4 2019 | |
| $1.85M | 0.25% | Not reported | -14.4% | Q4 2019 | |
| $1.75M | 0.24% | 0.00% | -11.1% | Q4 2019 | |
| $1.72M | 0.24% | 0.00% | -10.9% | Q4 2019 | |
| $1.21M | 0.17% | 0.00% | -5.5% | Q4 2020 | |
| $1.15M | 0.16% | 0.00% | -3.5% | Q4 2019 | |
| $1.14M | 0.16% | 0.63% | -48.3% | Q4 2019 | |
| $936K | 0.13% | 0.00% | -45.2% | Q4 2019 | |
| $917K | 0.13% | Not reported | -17.6% | Q4 2019 | |
| $907K | 0.12% | 0.00% | Not reported | Q4 2019 | |
| $904K | 0.12% | 0.00% | +2.0% | Q4 2019 | |
| $863K | 0.12% | 0.00% | -1.0% | Q4 2019 | |
| $754K | 0.10% | Not reported | Not reported | Q1 2025 | |
| $691K | 0.10% | 0.00% | -1.7% | Q4 2019 | |
| $641K | 0.09% | 0.02% | -0.1% | Q4 2019 | |
| $628K | 0.09% | 0.00% | -2.3% | Q4 2019 | |
| $614K | 0.08% | 0.00% | -47.1% | Q2 2020 | |
| $543K | 0.07% | 0.00% | -0.5% | Q4 2019 | |
| $513K | 0.07% | 0.02% | Not reported | Q4 2019 | |
| $479K | 0.07% | 0.00% | -3.3% | Q4 2019 | |
| $479K | 0.07% | 0.00% | -5.7% | Q4 2019 | |
| $463K | 0.06% | 0.00% | -25.7% | Q1 2021 | |
| $461K | 0.06% | 0.00% | -6.2% | Q4 2019 | |
| $450K | 0.06% | 0.00% | -1.4% | Q4 2019 | |
| $439K | 0.06% | 0.00% | -13.8% | Q4 2019 | |
| CPCNTACentessa Pharmaceuticals PLC | $439K | 0.06% | 0.01% | -52.5% | Q2 2025 |
| $404K | 0.06% | Not reported | Not reported | Q4 2019 | |
| $387K | 0.05% | 0.00% | -31.1% | Q4 2019 | |
| $380K | 0.05% | 0.00% | -6.8% | Q1 2020 | |
| $360K | 0.05% | 0.00% | -5.5% | Q4 2019 | |
| $340K | 0.05% | 0.00% | -5.9% | Q4 2019 | |
| $336K | 0.05% | 0.00% | -5.0% | Q2 2020 | |
| $328K | 0.05% | 0.00% | +0.3% | Q1 2021 | |
| $326K | 0.04% | 0.00% | -19.4% | Q4 2019 | |
| $306K | 0.04% | 0.00% | -8.5% | Q4 2019 | |
| $299K | 0.04% | Not reported | Not reported | Q4 2019 | |
| $294K | 0.04% | 0.00% | -34.5% | Q4 2019 | |
| $293K | 0.04% | 0.00% | -24.7% | Q4 2019 | |
| $282K | 0.04% | 0.00% | Not reported | Q4 2019 | |
| $277K | 0.04% | 0.00% | -1.0% | Q1 2021 | |
| $269K | 0.04% | 0.00% | New | Q3 2025 | |
| $262K | 0.04% | 0.00% | -3.6% | Q4 2019 | |
| $257K | 0.04% | 0.00% | -1.8% | Q4 2019 | |
| $256K | 0.04% | 0.00% | -59.9% | Q2 2025 | |
Premium opens every quarter this fund has filed